Am J Ind Med by Calvert, Geoffrey M. et al.
The Prevalence of Selected Potentially Hazardous Workplace 
Exposures in the US: Findings From the 2010 National Health 
Interview Survey
Geoffrey M. Calvert, MD, MPH1,*, Sara E. Luckhaupt, MD, MPH1, Aaron Sussell, PhD, MPH1, 
James M. Dahlhamer, PhD2, and Brian W. Ward, PhD2
1Division of Surveillance, Hazard Evaluations and Field Studies, National Institute for 
Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, Ohio 
2Division of Health Interview Statistics, National Center for Health Statistics, Centers for Disease 
Control and Prevention, Hyattsville, Maryland
Abstract
Objective—Assess the national prevalence of current workplace exposure to potential skin 
hazards, secondhand smoke (SHS), and outdoor work among various industry and occupation 
groups. Also, assess the national prevalence of chronic workplace exposure to vapors, gas, dust, 
and fumes (VGDF) among these groups.
Methods—Data were obtained from the 2010 National Health Interview Survey (NHIS). NHIS is 
a multistage probability sample survey of the civilian non-institutionalized population of the US. 
Prevalence rates and their variances were calculated using SUDAAN to account for the complex 
NHIS sample design.
Results—The data for 2010 were available for 17,524 adults who worked in the 12 months that 
preceded interview. The highest prevalence rates of hazardous workplace exposures were typically 
in agriculture, mining, and construction. The prevalence rate of frequent handling of or skin 
contact with chemicals, and of non-smokers frequently exposed to SHS at work was highest in 
mining and construction. Outdoor work was most common in agriculture (85%), construction 
(73%), and mining (65%). Finally, frequent occupational exposure to VGDF was most common 
among mining (67%), agriculture (53%), and construction workers (51%).
Conclusion—We identified industries and occupations with the highest prevalence of 
potentially hazardous workplace exposures, and provided targets for investigation and intervention 
activities.
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INTRODUCTION
Little nationally representative information on US workplace hazard exposures is available. 
Additional national prevalence estimates of workplace exposures are needed to characterize 
current workplace exposures so that exposure reduction interventions can be appropriately 
targeted, and to assess the impact of the many changes in materials, processes, equipment, 
work practices, and the workforce that have taken place in the past several decades [Shire et 
al., 2011].
This report provides findings from the 2010 National Health Interview Survey (NHIS)—
Occupational Health Supplement (OHS) that focus on workplace exposures over the 
previous 12 months involving skin contact/handling of chemicals, regular exposure to 
secondhand smoke (SHS), and working outdoors at least twice weekly (a risk factor for 
heat-related illness). In addition, this report provides findings on exposure to airborne 
chemical substances and dusts at the job held longest by the respondent in their lifetime. 
Differences in prevalence of exposures by demographic characteristics, industry of 
employment, and occupation are examined.
METHODS
National Health Interview Survey (NHIS)
NHIS is a cross-sectional in-person household survey conducted continuously since 1957 by 
the National Center for Health Statistics (NCHS), Centers for Disease Control and 
Prevention (CDC), and is used to monitor the health of the nation. Data are collected on the 
civilian non-institutionalized population of the US, and exclude persons in long-term care 
facilities (e.g., nursing homes) or correctional facilities, active-duty Armed Forces personnel 
(although civilian family members are included), and US nationals residing in foreign 
countries [Pleis et al., 2010; National Center for Health Statistics, 2011]. The survey uses a 
multi-stage clustered sample design, with an over-sampling of black, Hispanic, and Asian 
persons. Black, Hispanic, and Asian adults aged 65 or older are also over-sampled to 
complete the sample adult module, which, as described later, is one of the four main NHIS 
modules. NHIS produces nationally representative data on health insurance coverage, health 
care access and utilization, health status, health behaviors, and other health-related topics.
The NHIS questionnaire consists of a core set of questions that remain relatively unchanged 
from year to year, and supplemental questions that vary from year to year which collect 
additional data pertaining to current health issues of national importance. In 2010, the survey 
instrument had four main modules: household, family, sample child, and sample adult. The 
first two modules collected health and sociodemographic information on each member of 
each family residing within a sampled household. Within each family, additional 
information was collected from one randomly selected adult (the “sample adult”) aged 18 
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years or older. In rare instances when a sample adult was physically or mentally unable to 
respond, proxy responses were accepted (<1.5% of sample). Interviews were conducted in-
person (some telephone follow-up is allowed) using computer assisted personal interviewing 
(CAPI). A total interview lasted on average about 1 hr. In 2010, NHIS interviews were 
conducted in 34,329 households, accounting for 89,976 persons in 35,177 families. The 
estimates presented in this paper are based on data collected from 27,157 sample adults. The 
household response rate was 79.5%, the conditional sample adult response rate (i.e., the 
response rate for those sample adults identified as eligible) was 77.3%, and the final sample 
adult response rate (i.e., the response rate that takes into account both the conditional sample 
adult response rate and the household/family response rate) was 60.8%.
Information regarding industry and occupation of employment, occupational exposures, and 
smoking were obtained from core and OHS questions included in the sample adult module. 
Demographic characteristics were obtained from questions asked in the household and 
family modules.
The 2010 National Health Interview Survey (NHIS) was approved by the Research Ethics 
Review Board of the National Center for Health Statistics (Protocol #2009-16) and the US 
Office of Management and Budget (Control #0920-0214). Written consent for participation 
in the 2010 NHIS was not received, but instead all 2010 NHIS respondents provided oral 
consent prior to participation.
Study Definitions
The questions on workplace exposures were only asked of sample adults who were currently 
employed or employed at some time in the 12 months prior to interview. In the questions 
that began “During the past 12 months,” the subject was asked about exposures during the 
past 12 months in the main job the respondent held in the week preceding interview. If the 
respondent was not working in the preceding week, these questions were addressed to the 
job held most recently. It did not matter if the main job or most recent job was full-time or 
part-time. Potential skin hazards were assessed with the question “During the past 12 
months, did you regularly handle or were you in skin contact with chemical products or 
substances at work twice a week or more?” Those who answered “yes” were defined as 
having frequent occupational skin contact with chemicals during the past 12 months. 
Exposure to SHS was assessed with the question “During the past 12 months, were you 
regularly exposed to tobacco smoke from other people at work twice a week or more?” 
Those who answered “yes” were defined as having frequent workplace exposure to SHS 
during the past 12 months. Most analyses of exposure to SHS were limited to current non-
smokers because it is possible that smokers were exposed in designated smoking areas. 
Working outdoors was assessed with the question “During the past 12 months, did you 
regularly work outdoors twice a week or more?” Those who answered “yes” were defined as 
frequently working outdoors during the past 12 months. Inhalational exposure to vapors, 
gas, dust, or fumes (VGDF), which is a measure of exposure to airborne chemical 
substances and dusts, was assessed with the question “Please tell me if you are/were 
regularly exposed to vapors, gas, dust, or fumes at work twice a week or more?” Those who 
answered “yes” were defined as having frequent occupational exposure to VGDF at their 
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longest-held job. The VGDF question was asked about the longest held job in the 
respondent's lifetime only, as the health effects associated with VGDF exposure are often 
not acute, but instead develop after many months and years of exposure.
Those who had worked in the 12 months that preceded the interview were also classified 
according to several demographic characteristics: sex, age group, race/ethnicity, marital 
status, education, current smoking status, place of residence, and geographic region. 
Analyses by educational status were limited to workers aged 25 years and over. Non-
smokers were defined as those respondents who had never smoked a cigarette, smoked 
fewer than 100 cigarettes in their lifetime, or who had smoked 100 cigarettes or more in 
their lifetime but did not currently smoke [Schoenborn and Adams, 2010]. Geographic 
classification was based on the location of a respondent's home, and included region 
(Northeast, Midwest, South, and West) and place of residence. For place of residence, a 
metropolitan statistical area (MSA) is defined by the US Office of Management and Budget 
and is typically centered around a single large city that wields substantial influence over the 
region included in the MSA. Large MSAs have a population size of 1,000,000 or more, 
small MSAs have a population size of less than 1,000,000, and “not in MSA” consists of 
persons not living in a MSA.
Open-ended responses were obtained from each employed sample adult respondent 
regarding his/her industry (employer's type of business) and occupation (employee's type of 
work), both for the main job held in the 12 months preceding interview and for the longest 
held job. These responses were reviewed by US Census Bureau coding specialists who 
assigned 4-digit industry and occupation codes. The data were coded using US Census codes 
based on the 2007 North American Industrial Classification System (NAICS) and 2010 
Standard Occupational Classification (SOC) system. To allow for sufficient sample size for 
more reliable estimates, we primarily used simple (i.e., less detailed) 2-digit industry and 
occupation (I&O) recodes. The industry recodes include 21 simple categories, and the 
occupation recodes include 23 simple categories. However, in a few instances we examined 
the detailed I&O recodes within a simple recode category. Detailed I&O recodes were used 
when the simple recode category met the following criteria: relatively substantial sample 
size (>900 sample adults); high observed prevalence rate for at least one exposure; and, 
anticipated to have a relatively wide spectrum of exposure prevalence across its detailed 
I&O recode categories.
Data Analyses—To account for the complex sampling design of the NHIS, analyses of 
the 2010 data were completed using SAS-callable SUDAAN software version 10.0 [RTI, 
2008]. To represent the US civilian, non-institutionalized population age 18 years and over, 
all prevalence estimates were weighted using the NHIS individual sample adult record 
weight. Point estimates with relative standard error (RSE) >30% and ≤50% are noted with 
an asterisk symbol (*), and estimates with RSE >50% are not reported.
If the estimates of two independent prevalence rates have 95% confidence intervals that do 
not overlap, then the two prevalence rates are considered significantly different (P < 0.05). 
When there is overlap in the two confidence intervals, the two independent prevalence rates 
may or may not be significantly different. Therefore, two sample z-tests were used to 
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compare select prevalence rates, and the resulting statistically significant differences (P < 
0.05) were reported in the Results section. Not all comparisons were evaluated nor are all 
statistically signifi-cant findings reported in the Results section. In addition to these 
statistically significant comparisons of independent prevalence rates, we also tested for 
statistically significant differences between I&O groups with the highest exposure 
prevalence rates compared to the prevalence rate for all current/recent workers combined. 
These significance tests were adjusted such that the estimated standard error of the 
difference between prevalence rates for I&O groups and all current/recent workers 
accounted for non-independence of I&O groups and all current/recent workers by 
incorporating their covariance [a method used in Cohen and Makuc, 2008]. All comparisons 
reported in the results section are significantly different at the P < 0.05 level.
RESULTS
Exposure data in the 2010 NHIS were available for 17,524 sample adults who worked in the 
12 months preceding interview. This sample represented approximately 155.3 million non-
institutionalized US adults.
Prevalence Rate of Frequent Occupational Skin Contact with Chemicals
The prevalence rate of frequent occupational skin contact with chemicals during the 12 
months preceding the interview among sample adult workers was 20.6% (Table I). The 
prevalence rate was higher among workers who were male (23.4%) compared to females 
(17.4%); lowest among workers aged ≥65 years old (11.1%) compared to other ages; highest 
among workers who had a high school diploma (27.1%) or less education (27.3%) compared 
to those with higher education levels; and, highest among workers who did not reside in a 
MSA (26.1%) compared to residing in one.
Prevalence Rate of Frequently Working Outdoors
The prevalence rate of frequently working outdoors during the 12 months preceding the 
interview was 24.7% (Table I). The prevalence was higher among workers who were male 
(37.2%) compared to females (10.9%); highest among workers who were Hispanic (31.8%) 
compared to all other races/ethnicities; highest among workers who had less than a high 
school diploma (39.5%) compared to those with higher education levels; highest among 
workers who did not reside in a MSA (32.7%) compared to residing in one; and, highest 
among workers who resided in the Western (26.9%) or Southern US (26.5%) compared to 
other regions.
Prevalence Rate of Frequent Workplace Exposure to Secondhand Smoke (SHS)
The prevalence rate of frequent workplace exposure to SHS during the 12 months preceding 
the interview was 14.9% for all workers, and 10.0% for current non-smoking workers (Table 
I). Among current non-smokers, the prevalence rate was higher among workers who were 
male (13.1%) compared to females (6.7%); highest among workers who were aged 18–29 
years old (13.6%) compared to other ages; higher among non-Hispanic blacks (14.5%) and 
Hispanics (12.2%) compared to non-Hispanic whites (8.9%) and Asians (6.8%); lowest 
among workers who had a Bachelor's degree or higher (4.7%) compared to those with lower 
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education levels; and highest among workers who resided in the Southern US (11.6%) 
compared to other regions.
Prevalence Rate of Frequent Occupational Exposure to VDGF at their Longest-Held Job
Among sample adult workers, the prevalence rate of frequent occupational exposure to 
VDGF at their longest-held job was 25% (Table I). The prevalence was higher among 
workers who were male (33.3%) compared to females (15.8%); highest among workers who 
were aged 30–64 years old (26.7%) compared to other ages; lowest among non-Hispanic 
Asians (12.3%) compared to other races/ethnicities; highest among workers who had a high 
school diploma (35.7%) or less education (38.1%) compared to those with higher education 
levels; highest among workers who did not reside in a MSA (34.0%) compared to those 
residing in one; and, highest among workers who resided in the Midwest (26.7%) or South 
(25.8%) compared to workers who resided in the Northeast (22.4%) or West (23.8%).
Workplace Exposures by Industry from the 2010 NHIS–OHS
For three of the four exposures that were investigated, mining was the industry category 
with the highest observed prevalence rate. Mining had the highest observed prevalence rate 
of frequent exposure to skin contact with chemicals (38.5%), non-smokers exposed to 
workplace SHS (28.4%), and chronic occupational exposure to VDGF (66.8%; Table II). 
The three industry categories that had the highest observed prevalence rate of workers who 
frequently worked outdoors were agriculture, forestry, fishing, and hunting (84.6%), 
construction (72.7%), and mining (65.4%). Construction also had a relatively high 
prevalence rate of workers exposed to the other three hazardous exposures [third highest 
observed prevalence rate of skin contact with chemicals (31.2%), second highest observed 
prevalence rate of non-smokers exposed to workplace SHS (23.8%), and third highest 
observed with VDGF exposure (51.1%)]. After mining and construction, the industry 
category with the highest observed prevalence rate of non-smoking workers exposed to 
workplace SHS were the arts, entertainment, and recreation industries (18.2%). Within 
manufacturing, workers employed in primary metal (e.g., steel mills and foundries) had high 
prevalence rates of skin contact with chemicals (48.1%) and VDGF exposure (65.5%) 
(Table III). Within other services, workers employed in repair and maintenance, and 
personal services (e.g., beauty and nail salons, dry cleaners, and funeral homes) had high 
prevalence rates of skin contact with chemicals (52.4% and 51.5%, respectively) and VDGF 
exposure (68.0% and 48.1%, respectively) (Table III). Industry categories that tended to 
have the lowest prevalence rate of workers exposed to these work-place hazards included 
several services subsectors: finance and insurance; professional, scientific, and technical 
services; and education services. When compared to all current/recent workers, all of the 
prevalence rates reported in this paragraph were statistically significant (P < 0.05).
Workplace Exposures by Occupation from the 2010 NHIS–OHS
Among occupation categories, construction and extraction workers had among the highest 
observed prevalence rates for the four workplace exposures (Table IV). For example, 
construction and extraction occupations accounted for the highest observed prevalence rate 
of non-smoking workers exposed to workplace SHS (28.5%), and the second highest rate for 
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exposures to VGDF (57.6%), and these findings were largely driven by construction trades 
workers (Table V). Those employed in installation, maintenance, and repair occupations had 
the highest observed prevalence rate exposed to VGDF (64.2%). Similarly, transportation 
and material moving occupations had high observed prevalence rates of workers exposed to 
three of the four exposures that were investigated (i.e., all but frequent skin contact with 
chemicals). The three occupational categories with the highest observed prevalence rate of 
workers who frequently worked outdoors were farming (90.1%), construction and extraction 
occupations (79.5%), and protective service occupations (i.e., police, firefighters, and 
guards, 59.3%). Protective service occupations also had one of the highest observed 
prevalence rates of non-smokers exposed to SHS (20.2%). Production occupations had a 
high prevalence rate of workers with VDGF exposure (53.2%), and skin contact with 
chemicals (35.9%), particularly printing workers (76.1% and 55.7%, respectively), and 
metal and plastic workers (69.7% and 49.2%, respectively) (Table V). The occupation 
category with the highest observed prevalence rate of workers with frequent skin contact 
with chemicals was building and grounds cleaning and maintenance occupations (55.4%). 
The prevalence rate of exposure to these hazards was lowest among many traditional white-
collar occupation categories including: computer and mathematical occupations; and 
business and financial operations occupations. Education, training, and library occupations 
comprised the occupation category with the lowest prevalence rate of non-smoking workers 
frequently exposed to workplace SHS (2.3%). When compared to all current/recent workers, 
all of the prevalence rates reported in this paragraph were statistically significant (P < 0.05).
DISCUSSION
This is one of the first reports providing results from the 2010 NHIS–OHS, and focused on 
the prevalence of four potentially hazardous workplace exposures. Furthermore, for the first 
time in at least 22 years, estimates based on a representative national sample are provided on 
workplace skin contact with chemicals, and workplace exposure to SHS. To our knowledge, 
this is the first report to provide national estimates on the prevalence of outdoor work and 
workplace exposure to VGDF.
Other Sources of Prevalence Estimates of Workplace Hazards in the US
The National Institute for Occupational Safety and Health (NIOSH) conducted two facility-
based national chemical exposure surveys; however, these surveys did not quantify chemical 
exposures and the last of these was completed in 1983—over 25 years ago [NIOSH, 1988]. 
Another source of exposure data is the National Health and Nutrition Examination Survey 
(NHANES) which provides national estimates of the body burden of many chemicals or 
their metabolites in the US population, and national estimates of a few self-reported 
exposures (e.g., noise) [CDC, 2009; Tak et al., 2009]. Finally, another national workplace 
exposure database is the Integrated Management Information System (IMIS), developed and 
maintained by the Occupational Safety and Health Administration (OSHA). IMIS consists 
of information collected during OSHA enforcement and consultation visits that were 
conducted between 1979 and the present, and contains over 1.6 million sampling 
measurements for 1,320 unique agents of exposure [Henn et al., 2011]. IMIS data have been 
used to characterize lead and noise exposures in US workplaces [Middendorf, 2004; Henn et 
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al., 2011]. However, since OSHA enforcement inspections and consultation visits rarely 
involve very small employers (<10 employees) and the self-employed, are not conducted 
using a random design, and often result from particular regulatory emphasis programs, it is 
unlikely that IMIS data are representative of all workers.
Information on dermal exposures and exposure to SHS are also available from the 1988 
NHIS, which was the last year a version of the NHIS–OHS was administered before 2010 
[Park et al., 1993]. However, the questions on potential skin hazards and SHS exposure were 
very different from those asked in 2010. In 1988, participants were asked about eight 
different skin exposures (e.g. solvents, pesticides, cutting oils). In addition, the frequency of 
exposure that was asked also differed between the two years. In 1988, each participant was 
asked whether “you got any of these things on your hands or arms at your job during the 
past 12 months” whereas in 2010 participants were asked “During the past 12 months, did 
you regularly handle or were you in skin contact with chemical products or substances at 
work twice a week or more?” SHS exposure was assessed in the 1988 NHIS–OHS with two 
questions: “Is smoking allowed in your place of work other than in designated areas?” and if 
the response was “yes,” the respondent was asked “Do you find that cigarette smoke in the 
work place causes you no discomfort, some discomfort, moderate discomfort, or great 
discomfort?” Due to the substantial differences in the questions asked in 1988 and 2010, a 
detailed comparison of findings between these two years was considered beyond the scope 
of this paper. The 1988 NHIS–OHS did not include questions on outdoor work or exposure 
to VGDF.
Workplace Skin Contact with Chemicals
The findings that males had a higher prevalence of workplace skin contact with chemicals is 
consistent with those from a study of New Zealand workers [Eng et al., 2011]. Eng et al. 
found that males were significantly more likely to report exposure to oils, solvents, acids, 
alkalis, and pesticides. Furthermore, they found that among males and females working in 
the same occupation, males were significantly more likely to be exposed to oils and 
solvents.
We identified the industry and occupation categories with the highest observed prevalence 
rates of workplace skin contact with chemicals during the 12 months preceding interview. 
These industries and occupations could be targeted with efforts to assess dermal exposures 
qualitatively (or quantitatively if appropriate). The findings from these in-depth exposure 
measurements could guide interventions to reduce exposures to causative agents for work-
related dermatitis.
Secondhand Smoke
SHS is associated with an increased risk for lung cancer and coronary heart disease, and 
there is no known risk-free level of exposure [U.S. Department of Health and Human 
Services, 2006]. Our findings suggest that the prevalence rate of workplace SHS exposure 
among non-smoking workers is 10%. Although this prevalence is relatively low, this 
represents 12.5 million non-smoking workers who are exposed to SHS twice per week or 
more [U.S. Department of Health and Human Services, 2006].
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Before 2002, there were no states that had comprehensive workplace smoke-free laws (i.e., 
laws that prohibited smoking in all indoor areas of these three venues: worksites, restaurants, 
and bars) [CDC, 2011]. By the end of 2010, there were 26 states with such laws. An 
additional 10 states prohibit smoking in up to two of the three venues. However, as of 2010, 
there were no states in the South that had comprehensive workplace smoke-free laws. This 
may contribute to the reason that in 2010 the South had the highest prevalence rate of non-
smoking workers exposed to SHS (11.6%).
After the home, the workplace is the most common site where adults spend most of their 
time [Klepeis et al., 2001]. As such, the workplace can be a major contributor to SHS 
exposure. Our findings identified the industry and occupation categories with the highest 
observed prevalence rates of workplace SHS exposure among non-smokers (e.g., 
construction) and these could be targeted with interventions to reduce these exposures.
Outdoor Work
Working outdoors under hot and humid conditions is a risk factor for heat-related illness 
[Bonauto et al., 2010]. Few studies have been conducted to assess the magnitude of 
occupational heat-related illness [Jackson and Rosenberg, 2010]. In a study of heat-related 
illness in Washington State in the years 2000 through 2009, industries with the highest risk 
for heat-related illness were construction (especially roofers and highway, street, and bridge 
construction), public administration (especially firefighting), and agriculture [Bonauto et al., 
2010], which is consistent with the findings of our study. The average maximum daytime 
temperature on the date of the heat-related illness in Washington State was 89F. Given the 
evidence that climate change is occurring [McMicheal et al., 2006], there is concern that the 
number of days with hot and humid temperatures will continue to increase. We also found 
other industries and occupations with a high prevalence rate of outdoor work (e.g., mining, 
utilities, and real estate rental and leasing) which were not reported to be at increased risk 
for heat-related illness in the Washington State study [Bonauto et al., 2010]. This difference 
could be a result of the small numbers of these workers in Washington State, or the fact that 
these industries have effective policies and procedures to prevent heat-related illness. 
Recommendations to prevent occupational heat-related illness are available and include: 
training management and workers on the prevention, recognition and management of heat-
related illness; establishing a heat acclimatization program; providing adequate hydration; 
and, providing cooling measures such as frequent rest breaks, shaded areas to rest and 
cooling equipment to dissipate heat [CDC, 2008; Jackson and Rosenberg, 2010]. It should 
also be noted that some employees with outdoor work are exposed to cold environments, 
which may place them at risk for hypothermia and frostbite [Delaney and Goldfrank, 2007].
Workplace Exposure to VGDF
In contrast to the other exposure questions included in the 2010 NHIS–OHS, the question on 
exposure to VGDF asked about the respondent's longest held job. Other studies have used a 
similar question to assess VGDF exposures during an individual's longest held job [Blanc et 
al., 2005]. In addition, the VGDF question has been used to assess the work-relatedness of 
lung diseases such as asthma [Blanc et al., 2005]. Those who reported VGDF exposure at 
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their longest-held job had a significantly elevated risk for adult-onset asthma (odds ratio = 
1.7, 95% confidence interval = 1.03–2.8) [Blanc al., 2005].
Similar to our findings, Eng et al. [2011] also found that males had a higher prevalence of 
workplace exposure to dust, smoke, fume, and gas. Furthermore, they found that among 
males and females working in the same occupation, males were significantly more likely to 
be exposed to smoke, fume, and/or gas. We are not aware of studies that compared VGDF 
exposure across any other demographic characteristics.
In addition to asthma and chronic obstructive pulmonary disease (COPD), associations 
between VGDF and other health outcomes can be examined in future studies using 2010 
NHIS–OHS data. These data may be useful in assessing the work-relatedness of chronic 
disease. However, investigators need to be familiar with the caveats of the VGDF question. 
To our knowledge, the VGDF has not been validated against actual industrial hygiene 
measurements; however, it has been compared to multi-exposure checklists and job-
exposure matrices (JEMs) created by experts who assessed the likelihood of exposure in 
occupation/industry categories. Among studies of those without lung disease, the sensitivity 
of the VGDF question compared to checklists and JEMs has ranged from 42% to 64% and 
the specificity from 74% to 91% [Quinlan et al., 2009]. The sensitivity and specificity of the 
VGDF question is similar among those with lung disease (sensitivity = 48–65%; specificity 
= 80–83%) [Quinlan et al., 2009].
Workers employed in the mining, construction, and agriculture, forestry, fishing and hunting 
industries had the highest observed prevalence rates of VGDF exposures. The occupation 
with the highest observed VGDF exposure prevalence rate was installation, maintenance, 
and repair. Consideration should be made for targeting these industries and occupations with 
interventions to reduce VGDF exposures.
Limitations
This study is subject to several limitations. First, all exposure estimates are based on self-
report, which are subject to recall and interviewer bias. Additionally self-reports may be 
inaccurate if the respondent was not fully informed about their workplace exposures 
[Schenker et al., 2010]. We are aware of no validation of the questions used to obtain these 
self-reported exposures; however, the VGDF question has been shown to have modest 
agreement with exposure checklists and JEMs [Quinlan et al., 2009]. Second, the questions 
regarding exposures to airborne chemicals and dusts, and skin exposures to chemicals do not 
provide any information about the toxicity of the substances or the intensity of the 
exposures. Self-reports are qualitative, and made by a non-experts, so it is not possible to 
infer whether or not the reported exposures would be deemed unacceptable if assessed by 
industrial hygienists. Using the question on outdoor work as a surrogate for exposure to heat 
and humidity has limitations, particularly since there may be some workers who frequently 
work outdoors only under cool or cold conditions. Additionally heat stress depends greatly 
on whether the workplace has effective policies and procedures to prevent heat-related 
illness. Finally, there are also limitations associated with the I&O groups used in these 
analyses. The simple I&O categories lumped together workers who likely had substantially 
different workplace exposures, and different intensities of exposure. Using more specific 
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I&O categories led to smaller cell sizes and less reliable estimates. Finally, the economic 
climate and high unemployment rates in the US during 2010 should also be considered when 
interpreting our findings as these conditions could have influenced the NHIS-OHS 
estimates.
CONCLUSIONS
We identified industry and occupation categories with the highest observed prevalence rates 
for potentially hazardous workplace exposures. These data provide some potential industry 
and occupation categories that could serve as potential targets both for further investigation 
and potential intervention activities. Among US adult workers, the prevalence rate of 
frequent occupational skin contact with chemicals during the 12 months preceding interview 
was 20.6%. The prevalence rate of frequent workplace exposure to SHS among non-
smoking workers during the 12 months preceding interview was 10.0%. The prevalence rate 
of frequently working outdoors during the 12 months preceding interview was 24.7%. The 
prevalence rate of frequent occupational exposure to VDGF at one's longest-held job was 
25.0%. Workers employed in construction, mining and installation, maintenance and repair 
were observed to have among the highest prevalence rates for the four workplace exposures, 
and were significantly elevated compared to the rates among all current/recent workers.
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